Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study to Explore the Role of Alpha-Synuclein-related Biomarkers in the Diagnosis and Disease Evaluation of Parkinson's Disease and Other Synucleinopathies

NCT05638815 is registered in ClinicalTrials.gov with SciNeuro as lead sponsor.

NCT NCT05638815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05638815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study to Explore the Role of Alpha-Synuclein-related Biomarkers in the Diagnosis and Disease Evaluation of Parkinson's Disease and Other Synucleinopathies
Lead sponsor
SciNeuro
Phase
Observational
Overall status
Completed
Start date
November 23, 2021
Completion date
July 10, 2023
Enrollment
89 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

multiple system atrophy, parkinson's disease